Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Basma Adeem Medical Co.SAU:9626 21 Return-on-Tangible-Equity is 24.52% as of Dec. 2025, which is 8% below its 10-year median of 26.63. GuruFocus rates SAU:9626 with a GF Score™ of 21/100. The stock has 1 warning sign investors should review. Among 576 Healthcare Providers & Services companies, Basma Adeem Medical Co. ranks better than 69.79% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Basma Adeem Medical Co.'s annualized net income for the quarter that ended in Dec. 2025 was ﷼9.50 Mil. Basma Adeem Medical Co.'s average shareholder tangible equity for the quarter that ended in Dec. 2025 was ﷼38.73 Mil. Therefore, Basma Adeem Medical Co.'s annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 was 24.52%.
The historical rank and industry rank for Basma Adeem Medical Co.'s Return-on-Tangible-Equity or its related term are showing as below:
SAU:9626'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 21.96 Med: 26.63 Max: 28.24
Current: 21.96
During the past 2 years, Basma Adeem Medical Co.'s highest Return-on-Tangible-Equity was 28.24%. The lowest was 21.96%. And the median was 26.63%.
SAU:9626's Return-on-Tangible-Equity is ranked better than 69.79% of 576
companies
in the Healthcare Providers & Services industry
Industry Median: 10.17
vs SAU:9626: 21.96
Basma Adeem Medical Co. (SAU:9626) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Basma Adeem Medical Co. Return-on-Tangible-Equity Related Terms
Basma Adeem Medical Co. Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Basma Adeem Medical Co.'s Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Basma Adeem Medical Co. Return-on-Tangible-Equity Chart
Basma Adeem Medical Co. Annual Data
Trend
Dec24
Dec25
Return-on-Tangible-Equity
28.24
25.02
Basma Adeem Medical Co. Semi-Annual Data
Jun24
Dec24
Jun25
Dec25
Return-on-Tangible-Equity
0.00
35.11
16.05
24.52
SAU:9626 vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, Basma Adeem Medical Co.'s Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Basma Adeem Medical Co. Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Basma Adeem Medical Co.'s Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Basma Adeem Medical Co.'s Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 24.52% mean?
Basma Adeem Medical Co. (SAU:9626) has a Return-on-Tangible-Equity of 24.52% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Basma Adeem Medical Co. and its competitors. This is near median its historical median of 26.63. Over the past decade, Basma Adeem Medical Co.'s Return-on-Tangible-Equity has ranged from 21.96 to 28.24. According to the industry distribution chart, Basma Adeem Medical Co. ranks #174 out of 576 companies in the Healthcare Providers & Services industry, placing it in the top 30.2%.
Is Basma Adeem Medical Co.'s Return-on-Tangible-Equity too high?
Basma Adeem Medical Co.'s current Return-on-Tangible-Equity of 24.52% is near median its 10-year median of 26.63. Over the past 10 years, this metric has ranged from a low of 21.96 to a high of 28.24. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.17. Basma Adeem Medical Co.'s value of 24.52% is 141.1% above this industry median. Based on the distribution chart, Basma Adeem Medical Co. ranks #174 out of 576 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Basma Adeem Medical Co. has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Basma Adeem Medical Co.'s Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Basma Adeem Medical Co. ranks #174 out of 576 companies for Return-on-Tangible-Equity. This puts Basma Adeem Medical Co. in the upper half of its industry. The industry median Return-on-Tangible-Equity is 10.17. Basma Adeem Medical Co.'s value of 24.52% is 141.1% above this benchmark. Historically, Basma Adeem Medical Co.'s own Return-on-Tangible-Equity has ranged from 21.96 to 28.24 over the past decade. While the company's 10-year median is 26.63 vs. the industry median of 10.17, Basma Adeem Medical Co. has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.17, based on 576 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Basma Adeem Medical Co.'s current Return-on-Tangible-Equity of 24.52% is 141.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Basma Adeem Medical Co. and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Basma Adeem Medical Co.'s current Return-on-Tangible-Equity is 24.52%, which is near median its own 10-year median of 26.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Basma Adeem Medical Co. stock overvalued right now?
Basma Adeem Medical Co. (SAU:9626) has a current Return-on-Tangible-Equity of 24.52%. The current Return-on-Tangible-Equity is 24.52%, which is near median its 10-year median of 26.63 and 141.1% above the Healthcare Providers & Services industry median of 10.17. Basma Adeem Medical Co.'s overall GF Score™ is 21/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Basma Adeem Medical Co. (SAU:9626), the current Return-on-Tangible-Equity is 24.52% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Basma Adeem Medical Co. operates in the field of dental medicine, treatment, and cosmetic dentistry. The company provides its services to clients through its professional and specialized medical staff in therapeutic and cosmetic dentistry.
21GF Score
Get the complete analysis for SAU:9626
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:9626 has been successfully added to your 
